Prolonged release of drug from triacetyl-β-CyD complex for oral and rectal administration
- 66 Downloads
- 2 Citations
Abstract
Triacetyl-β-cyclodextrin (TA-β-CyD), a hydrophobic cyclodextrin derivative, that is insoluble in water, was used to form a complex with flufenamic acid (FA). FA-TA-β-CyD complex formation was demonstrated by differential scanning calorimetry and powder X-ray diffractometry. The release rate of FA from the FA-TA-β-CyD complexes in phosphate buffer pH 6.8 was significantly retarded compared to that of FA from the FA and glucose mixture. When the FA-TA-β-CyD complexes were administered directly into the intraduodenal lumen, the plasma concentration of FA remained at a plateau level (10-18 μg/ml) for 6–8 h. An increased mean residence time of FA following FA-TA-β-CyD complexes administration was observed. These results indicate that TA-β-CyD may serve as a hydrophobic carrier in prolonged-release preparations of FA.
Keywords
Glucose Phosphate Buffer Plasma Concentration Differential Scanning Calorimetry CalorimetryPreview
Unable to display preview. Download preview PDF.
References
- [1]Chow D.D. and Karara A.H., Characterzation, dissolution and bioavailability in rats of ibuprofen-β-cyclodextrin complex system,Int.J.Pharm.,28, 95–101 (1986).Google Scholar
- [2]Uekama K., Horikawa T., Yamanaka M., Hirayama F., Peraclated β-cyclodextrins as novel sustained-release carrier for water-soluble drug, molsidomine,J.Pharm.Pharmacol. 46, 714–717 (1994).Google Scholar
- [3]Tsuruoka M., Hashimoto T., Sco H., Ichimasa S., Ueno O., Fujinaga T., Otagiri M., Uekama K., Enhanced Bioavailability of phenytoin by β-cyclodextrin complexation,Yakugaku Zasshi,101, 360–367 (1981).Google Scholar
- [4]Dusci L.J. and Hackett L.P., Determination of some antiinflammatory drugs in serum by high-performance liquid chromatography,J.Chromatogr.,172, 516–519 (1979).Google Scholar
- [5]Tanigawara Y., Yamaoka K., Nakagawa T., Uno T., Momeny analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products,J.Pharm.Sci.,71, 1129–1133 (1982)Google Scholar